Flanimus
Breathalyzer Test for Diagnosing Coronavirus
Startup Pre-Funding Health Tech & Life Sciences Est. 2020
Total Raised
Undisclosed
Pre-Funding
Last Round
Undisclosed
Team
1
1-10 employees
Confidence
75/100
About
Flanimus is a simple, one-minute breathalyzer test for diagnosing the coronavirus at the cost of three dollars per test. The Flanimus test can be performed at any location and by any operator, without the need for trained staff or dedicated labs. The device comprises two main parts: a disposable capsule with a chip inside and a spectrometer. After breathing into the capsule, it is inserted into the spectrometer, and the spectral signature of the virus is detected using proprietary software.
Classification
Sector
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesDigital HealthcareDigital Medical Diagnostics
Core Technology
Materials & SubstancesNanomaterialsSemiconductors & ElectronicsPlatforms & InterfacesSoftware
Target Customer
Travel & Tourism
Business Model
B2B
Tags
software-developmentdigital-healthcarediagnosticsairportsmedical-technologiesmedical-devices
Details
Product Stage
Clinical Trial
Employees
1-10
Exact Count
6
District
Center District
Founded
2020
Registrar
516321411
Locations
Rehovot, Israel
Links
Admin
Last Update
Apr 12, 2021
Verified by
Yotam Maman
Missing
logo, homepage, news, not claimed, funding rounds, markets, external profile
Team (1)
Gabby Sarusi
Founder
Founder
Internal
Created by
Jenny Sotnik-Talisman (genys30@yahoo.com)
Created
2021-01-17T00:00:00.000Z
Last editor
Jenny Sotnik-Talisman (genys30@yahoo.com)